Xtx Topco LTD Aurinia Pharmaceuticals Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.93 - $9.31 $115,810 - $218,701	23,491 New	23,491 $117,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $83,139 - $131,289	10,700 Added 78.9%	24,261 $188,000
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $121,506 - $158,528	13,561 New	13,561 $131,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $147,096 - $291,330	35,790 Added 109.27%	68,543 $296,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $129,883 - $241,629	19,502 Added 147.17%	32,753 $246,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $118,596 - $169,612	13,251 New	13,251 $133,000

191

56.7M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $996M
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.